Clinical trials: Defecation Disorder
- Condition Defecation Disorder
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Functional and Motility Related Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional Dyspepsia
A Pharmacy-based Study to Learn More About How Well Iberogast Works, How it Affects the Body, How it is Used, and User Satisfaction in Patients With Functional and Motility-related (Stomach and Bowel Movement-related) Gastrointestinal Diseases, Including Irritable Bowel Syndrome
Researchers want to learn more about the day-to-day use of Iberogast in people who have functional and motility-related gastrointestinal (stomach and bowel) diseases.
- Trial name
- NCT04993989
- Testing
- Iberogast (STW5, BAY98-7411)
- Where
- Germany
- Volunteers
- 843 people
- Sponsor
- Bayer
Constipation
International Multicenter Prospective Transtar Registry
Obstructed Defecation Syndrome (ODS) describes a condition which is characterized by chronic constipation. The symptoms of ODS include abdominal pain or cramping, irregular bowel frequency and the feeling of not having emptied…
- Trial name
- NCT00909116
- Testing
- Stapled Transanal Rectal Resection with Contour Transtar
- Where
- Belgium
- Volunteers
- 100 people
- Sponsor
- Ethicon Endo-Surgery (Europe) GmbH